Tempest Therapeutics, Inc. Dividends, Common Stock
Tempest Therapeutics, Inc. (TPST) reported Dividends, Common Stock of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Dividends, Common Stock
us-gaap:DividendsCommonStock · last filed 2026-08-13
- Tempest Therapeutics, Inc. dividends, common stock for the quarter ending 2026-06-30 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for the quarter ending 2026-03-31 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for the quarter ending 2025-09-30 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for the quarter ending 2025-06-30 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for fiscal 2024 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for fiscal 2023 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for fiscal 2022 was $0.00.
- Tempest Therapeutics, Inc. dividends, common stock for fiscal 2021 was $0.00.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month | Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-03-19 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-22 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |